Breaking news

Amazon SAS Advances €4 Million Pharmaceutical Facility in Limassol

by News Editor

May 27, 2025

Amazon SAS has received the green light from the Environmental Authority to construct a state-of-the-art pharmaceutical manufacturing plant in Limassol, Cyprus. This ambitious €4 million project is set to be situated in the industrious Pentakomo-Monagroulli zone, precisely 620 meters southeast of Monagroulli village.

The construction timeline, as per the environmental impact assessment from September 2024, anticipates around ten months for completion, subject to any unexpected hurdles.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Details of the Facility

The expansive factory will cover 4,405 square meters over three levels. The underground level is designated for parking and auxiliary spaces, the second level will host pharmaceutical production, while the third level will accommodate offices and further auxiliary areas.

Notably, the plant will focus on solid pharmaceutical products like tablets and capsules, aiming for an annual output of 40 to 50 million units. Packaging will be diversified between bottles and blister packs, projecting an annual volume of approximately 10 million packaging units.

Infrastructure and Accessibility

The plant’s infrastructure includes multiple access points, with a controlled vehicle entrance, loading bay, and dedicated green spaces. A total of 50 parking spaces will cater to employees and visitors, ensuring accessibility options. The site will adhere strictly to health, safety, and environmental protocols in alignment with Cypriot and EU standards.

Strategic Significance

This development signifies a significant boost to the local economy, potentially paving the way for further industrial advancements in the region. For insights into how this project fits into broader economic trends, consider exploring Cyprus Housing Market Slows Amid Rising Costs and Regional Divergence.

The Future Forbes Realty Global Properties

Sklavenitis Cyprus Sets A New Standard For Employee-Centric Benefits

by THEFUTURE.TEAM

September 12, 2025

Investing In Human Capital

In a bold move that underscores the growing importance of human capital in today’s business landscape, Sklavenitis Cyprus has taken innovative steps to ensure its workforce is both valued and supported. The supermarket chain has introduced a policy to pay a 14th salary to all employees—including those from Papantoniou Supermarkets—cementing its status as the sole retailer in Cyprus to implement such a comprehensive benefit.

A Significant Investment In People

This initiative is far from symbolic. With an estimated total cost of €2 million, it represents a committed investment in the company’s most valuable asset—its people. By providing an additional salary, Sklavenitis reinforces a culture of inclusivity and fairness, acknowledging every employee’s contribution to its success.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Robust Benefits For Long-Term Stability

Complementary to the 14th salary, the company has launched a robust benefits program designed to address both financial and personal security. An Automatic Cost of Living Adjustment (ATA) of 12.56 per cent ensures that wages remain aligned with inflation, safeguarding real income stability for its team members.

Comprehensive Health And Life Support

Sklavenitis further enhances employee welfare through access to a Group Life and Health Insurance Plan and a Provident Fund co-funded by the employer. These measures not only provide immediate protection but also empower employees to plan confidently for the future.

Exclusive Perks And Incentives

The company extends its commitment beyond conventional benefits by offering store discounts, a birth allowance, and holiday gift vouchers valued at €100 during both Easter and Christmas. These additional perks enhance employee satisfaction and underline Sklavenitis’ people-first ethos.

A Strategy For Mutual Success

In an industry where employee engagement directly impacts customer satisfaction, Sklavenitis’ comprehensive approach stands out as both a progressive and strategic business decision. By investing in its workforce, the company not only nurtures a supportive workplace but also drives superior corporate performance, setting a new benchmark for responsible employment practices in Cyprus.